Novel Anti-Aging Gene NM_026333 Contributes to Proton-Induced Aging via NCX1 Pathway

    Tomohiro Osanai, Makoto Tanaka, Kasumi Mikami, Maiko Kitajima, Toshiko Tomisawa, Koji Magota, Hirofumi Tomita, Ken Okumura
    TLDR The gene NM_026333 slows down aging by affecting the NCX1 pathway and could be targeted for anti-aging treatments.
    The study identified NM_026333 as a novel anti-aging gene that was downregulated in CF6-overexpressing transgenic and high salt-fed mice, which experienced proton-induced aging. The NM_026333 protein, consisting of 269 amino acids, rescued cells from aging hallmarks by binding to NCX1 and suppressing its reverse mode, preventing proton-induced epigenetic changes and autophagy impairments. Additionally, an NCX1 inhibitor extended the lifespan of transgenic mice, suggesting that targeting the NCX1 pathway could be a potential anti-aging therapy.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 11 results

      community SAFFLOWER OIL good alternative for Minoxidil?

      in Treatment  1 upvotes 4 years ago
      Safflower oil is suggested as an alternative to minoxidil for hair growth, with benefits including scalp conditioning and hair strength enhancement. Studies indicate it may also reverse scalp dermatitis, alopecia, and prevent premature grayness.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

    Similar Research

    5 / 1000+ results